Your browser doesn't support javascript.
loading
miR-19a/b and miR-20a Promote Wound Healing by Regulating the Inflammatory Response of Keratinocytes.
Li, Dongqing; Peng, Hongmei; Qu, Le; Sommar, Pehr; Wang, Aoxue; Chu, Tongbin; Li, Xi; Bi, Xinling; Liu, Queping; Gallais Sérézal, Irène; Rollman, Ola; Lohcharoenkal, Warangkana; Zheng, Xiaowei; Eliasson Angelstig, Sofie; Grünler, Jacob; Pivarcsi, Andor; Sonkoly, Enikö; Catrina, Sergiu-Bogdan; Xiao, Changchun; Ståhle, Mona; Mi, Qing-Sheng; Zhou, Li; Xu Landén, Ning.
Afiliação
  • Li D; Dermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Unit of Dermatology, Karolinska University Hospital, Stockholm, Sweden.
  • Peng H; Department of Dermatology, Center for Cutaneous Biology and Immunology Research, Henry Ford Health System, Detroit, Michigan, USA; Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA; MirnaTech International, LLC, Detroit, Michigan, USA.
  • Qu L; Department of Dermatology, Center for Cutaneous Biology and Immunology Research, Henry Ford Health System, Detroit, Michigan, USA; Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Sommar P; Department of Reconstructive Plastic Surgery, Karolinska University Hospital, Stockholm, Sweden.
  • Wang A; Department of Dermatology, The Second Hospital of Dalian Medical University, Dalian, China.
  • Chu T; Department of Wound Repair, The Second Hospital of Dalian Medical University, Dalian, China.
  • Li X; Dermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Unit of Dermatology, Karolinska University Hospital, Stockholm, Sweden.
  • Bi X; Department of Dermatology, Center for Cutaneous Biology and Immunology Research, Henry Ford Health System, Detroit, Michigan, USA; Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Liu Q; Department of Dermatology, Center for Cutaneous Biology and Immunology Research, Henry Ford Health System, Detroit, Michigan, USA; Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Gallais Sérézal I; Unit of Dermatology, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Genetics, Hôpital Henri Mondor, APHP, Créteil, France.
  • Rollman O; Department of Dermatology, Academic University Hospital, Uppsala, Sweden.
  • Lohcharoenkal W; Dermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Unit of Dermatology, Karolinska University Hospital, Stockholm, Sweden.
  • Zheng X; Department of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden.
  • Eliasson Angelstig S; Department of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden.
  • Grünler J; Department of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden.
  • Pivarcsi A; Dermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Medical Biochemistry and Microbiology (IMBIM), Uppsala University, Uppsala, Sweden.
  • Sonkoly E; Dermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Unit of Dermatology, Karolinska University Hospital, Stockholm, Sweden.
  • Catrina SB; Department of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden; Centrum for Diabetes, Academic Specialist Centrum, Stockholm, Sweden.
  • Xiao C; Department of Immunology and Microbiology, The Scripps Research Institute, San Diego, California, USA.
  • Ståhle M; Dermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Unit of Dermatology, Karolinska University Hospital, Stockholm, Sweden.
  • Mi QS; Department of Dermatology, Center for Cutaneous Biology and Immunology Research, Henry Ford Health System, Detroit, Michigan, USA; Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Zhou L; Department of Dermatology, Center for Cutaneous Biology and Immunology Research, Henry Ford Health System, Detroit, Michigan, USA; Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA.
  • Xu Landén N; Dermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Unit of Dermatology, Karolinska University Hospital, Stockholm, Sweden; Ming Wai Lau Centre for Reparative Medicine, Stockholm node, Karolinska Institute, Stoc
J Invest Dermatol ; 141(3): 659-671, 2021 03.
Article em En | MEDLINE | ID: mdl-32949564
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cicatrização / Pé Diabético / Úlcera por Pressão / MicroRNAs / Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: J Invest Dermatol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cicatrização / Pé Diabético / Úlcera por Pressão / MicroRNAs / Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: J Invest Dermatol Ano de publicação: 2021 Tipo de documento: Article